Deals review
Deals of the day
Biovator and BASF sign technology development agreement
Stockholm, December 18, 2009 The Sweden-based biotech company Biovator and the global chemical industry leader BASF have signed a collaboration agreement for final development of In Vitro test systems capable of identifying the potential of chemical compounds to induce allergic reaction in humans. The agreement also includes a five-year BASF option of final product deliveries. moreAgfa HealthCare signs four-year agreement with Chinese partners for distribution of radiography solutions, potentially worth 500 million US dollar
Mortsel, Belgium December 18, 2009 On this occasion, the Flemish Minister-President Kris Peeters will visit the Agfa-Gevaert Group headquarters in Mortsel (Belgium) later today (6.30 p.m.). At the press conference the Minister-President will speak about the importance and the further roll-out of the 'Medisch Centrum Vlaanderen' (Flanders Medical Center) action plan as a part of the 'Vlaanderen in Actie' (Flanders in Action) project. moreOmnicare Announces Acquisition of Continuing Care Rx
COVINGTON, Ky., Sep 01, 2010--Omnicare, Inc. (NYSE:OCR), a leading provider of pharmaceutical care for the elderly, today announced it has acquired Continuing Care Rx (CCRx), a privately owned institutional pharmacy provider based in Harrisburg, Pennsylvania. Financial terms of the agreement were not disclosed. moreDeals review search
By month
May 2013 April 2013 March 2013 February 2013 January 2013 December 2012 November 2012 October 2012 September 2012 August 2012 July 2012 June 2012 May 2012 April 2012 March 2012 February 2012 January 2012 December 2011 November 2011 October 2011 September 2011 August 2011 July 2011 June 2011 May 2011
Search by date
Most viewed deals
- Recommended acquisition of Acambis plc ("Acambis") by Sanofi Pasteur Holding ("Sanofi Pasteur") by way of scheme of arrangement Posting of Scheme Document
- Omnicare Announces Acquisition of Continuing Care Rx
- Bayer CropScience and Janssen PMP conclude research agreement:
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- Biovator and BASF sign technology development agreement
More recent deals
Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
ROCKVILLE, Md., September 1, 2010 -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it has entered into a long-term commercial manufacturing agreement with Diosynth RTP, Inc....
GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program
Marlborough, MA, August 31, 2010 – Xcellerex, Inc. announced today that Project GreenVax has agreed to acquire XDR GMP single-use production bioreactors from Xcellerex. The systems will be...
PharmaNet Joins Medidata Solutions’ CRO Partner Program
NEW YORK, N.Y. – August 31, 2010 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that PharmaNet Development Group has...
3M to Acquire Attenti Holdings S.A.
ST. PAUL, Minn. & TEL AVIV, Israel--August 31, 2010--3M announced today it has entered into a definitive agreement to acquire Attenti Holdings S.A. from an investor group led by Francisco...
SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
BOTHELL, Wash., Aug. 30, 2010 — SCOLR Pharma, Inc. (NYSE AMEX: DDD) today announced that it has signed an agreement with The Emerson Group to provide sales support for the Company’s new line of...
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
LONDON, RESEARCH TRIANGLE PARK, N.C. and ALISO VIEJO, Calif., Aug 30, 2010--GlaxoSmithKline (NYSE: GSK) and Valeant Pharmaceuticals International (NYSE: VRX) announced today the U.S. Food and Drug...
Intendis and KYTHERA Enter Licensing and Development Agreement on Adipolytic Agent for Aesthetic Dermatology Use
Berlin, August 30, 2010 -- Bayer HealthCare’s dermatology business Intendis and KYTHERA Biopharmaceuticals, Inc. today announced an agreement to develop and commercialize ATX-101; an adipolytic...
3M to Acquire Cogent Inc.
ST. PAUL, Minn. & PASADENA, Calif.--August 30, 2010--3M (NYSE:MMM), and Cogent Inc. (NASDAQ:COGT) announced today that they have entered into a definitive agreement for 3M’s acquisition of Cogent...
Meda acquires Alaven, a US specialty pharma company
August 30, 2010 -- Meda has signed an agreement to acquire the US specialty pharmaceutical company Alaven. The acquisition will significantly enhance Meda’s marketing capabilities in the US and...
Sequella and University of Maryland Restate Exclusive License for Jointly-owned Event Marker System Technology
Rockville, MD - August 30, 2010- Sequella, Inc., a clinical-stage company focused on commercialization of novel drugs for life-threatening infectious diseases, announced today the restatement of...
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Year
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us